BMO lifts target for AMN Healthcare stock to USD 43.00
Published on 10/15/2026 at 21:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and market position
- On October 9, 2026, BMO Capital raised its AMN target from USD 40.00 to USD 43.00, 8.72 percent above the NYSE price.
- Second-quarter 2026 revenue reached USD 673.24 million, up 2.30 percent year over year.
- AMN Healthcare stock costs EUR 35.30 at Lang & Schwarz on October 15, 2026 at 9:32 p.m. CEST, up 5.02 percent on the NYSE.
- AMN had a USD 1.5 billion market capitalization and a 14.75 price-to-earnings ratio on October 15, 2026.
BMO Capital raised its AMN Healthcare target from USD 40.00 to USD 43.00 on October 9, 2026, putting the target 8.72 percent above the NYSE price of USD 39.55. According to Markets Insider, the analyst kept an Outperform rating while previewing third-quarter results. At Lang & Schwarz, AMN traded at EUR 35.30 on October 15, 2026 at 9:32 p.m. CEST.
Analyst target sets a higher bar
The revised target gives investors a concrete benchmark as AMN approaches its next results update. BMO cited stronger staffing industry metrics and potential upside to quarterly guidance in its October 9 note, according to Markets Insider. The target is 8.72 percent above the NYSE quote used for the comparison.
Revenue provides the operating test
AMN generated USD 673.24 million of revenue in the second quarter of 2026, a 2.30 percent year-over-year increase. MarketBeat also reported earnings per share of USD 0.77 for that quarter, compared with consensus of USD 0.19. The revenue figure matters because the next report will show whether staffing demand is translating into broader top-line growth.
Price position and valuation
The NYSE quote was USD 39.55 at 3:32 p.m. ET on October 15, 2026, up 5.02 percent from the USD 37.66 prior close. It stood 0.30 percent below the USD 39.67 52-week high and traded above the USD 14.97 52-week low. AMN's market capitalization was USD 1.5 billion and its price-to-earnings ratio was 14.75 on October 15, 2026.
November 5 results date
AMN has scheduled its third-quarter 2026 results release and conference call for November 5, 2026. The release is expected after the market close, followed by a call at 5:00 p.m. ET, according to Yahoo Finance. The company is listed on the New York Stock Exchange under the ticker AMN.
Comparison with peers
The following market figures are dated October 15, 2026.
AMN (NYSE, USD): plus 5.02 percent, P/E 14.75, market capitalization USD 1.5 billion
Privia Health Group (Nasdaq, USD): plus 4.76 percent, P/E 104.66, market capitalization USD 2.9 billion
HCA Healthcare (NYSE, USD): minus 0.16 percent, P/E 15.72, market capitalization USD 101.7 billion
Stock position in one view
The combination of a USD 43.00 BMO target, a 0.30 percent distance to the 52-week high and the November 5 reporting date gives the stock a defined set of near-term reference points. The operating question is whether second-quarter revenue growth can broaden before the next results update.
The further course of trading is shown by the continuously updated real-time quote of AMN Healthcare stock.
AMN Healthcare market data
- Company: AMN Healthcare Services, Inc.
- ISIN: US0017441017
- Ticker: AMN
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 9:32 p.m. CEST): EUR 35.30
- Market capitalization: USD 1.5 billion (as of October 15, 2026)
- 52-week range: USD 14.97-39.67 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
